Birds of a feather Several Wall Street analysts have similar ideas about how the S&P 500 will fare this year. The consensus ...
BMO Capital Markets raised its rating recommendation on Everest Group (NYSE:EG) stock to Outperform from Market Perform on ...
A recent surge in U.S. Treasury yields may gain even more momentum after a strong jobs report reinforced expectations that ...
WASHINGTON >> U.S. job growth unexpectedly accelerated in December while the unemployment rate fell to 4.1% as the labor ...
Staff cuts could leave IGM Biosciences with fewer than 55 employees. The company is also halting development of two ...
BMO Capital upgraded Atlassian (TEAM) to Outperform from Market Perform with a price target of $292, up from $255. The firm says its confidence ...
BMO Capital lowered the firm’s price target on American Electric (AEP) to $100 from $108 and keeps an Outperform rating on the shares. The ...
A December gain of 256,000 blew past forecasts, and unemployment fell to 4.2 percent. But markets recoiled as interest rate cuts seemed more distant.
Mihelic hiked his price target on Toronto-listed BMO shares from $133 to $161, while upgrading his rating to “Outperform” ...
周五，BMO Capital Markets调整了对Intellia Therapeutics股票的展望，将目标价从之前的70美元下调至50美元，同时维持"跑赢大市"评级。此次调整是在Intellia Therapeutics分享了其展望2025年的战略计划之后做出的，该计划包括专注于执行ATTR和HAE的III期试验，目标是在2027年前获得HAE的批准。
周五，BMO Capital Markets分析师将Precision BioSciences Inc. (NASDAQ: DTIL)的股票评级从"市场表现"上调至"跑赢大市"，并设定34.00美元的目标价。这一乐观展望是在iECURE宣布使用DTIL的体内基因编辑器ARCUS的临床数据令人鼓舞之后做出的。
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback